Atorvastatin, Clopidogrel and Aspirin Capsules

Atorvastatin 10mg, Clopidogrel 75 mg, and Aspirin 75 mg Capsules - Atorvastatin belongs to the ‘statin’ class of drugs. These drugs are used to maintain the lipid profile and prevent the events associated with cardiovascular diseases. Clopidogrel is a prodrug of a platelet inhibitor used to reduce the risk of myocardial infarction and stroke. Whereas,  Aspirin is used to prevent a first heart attack in people with heart disease risk factors, such as diabetes and high cholesterol. This triple-action combination is primarily used to prevent heart attacks, strokes, and blood clots in high-risk patients. Arlak Corazon is a leading producer and supplier of Atorvastatin 10mg, Clopidogrel 75 mg, and Aspirin 75 mg sold under the brand name CORAVAS Gold 20. 

Mechanism of Action of  Atorvastatin 10mg, Clopidogrel 75 mg, and Aspirin 75 mg Capsules

• Atorvastatin: Inhibits HMG-CoA reductase, the key enzyme in cholesterol synthesis, leading to reduced LDL cholesterol and triglycerides and modestly increased HDL cholesterol. This slows atherosclerotic plaque formation and improves vascular health.
• Clopidogrel Bisulfate: A thienopyridine derivative that irreversibly blocks P2Y12 receptors on platelets, preventing ADP-mediated platelet activation and aggregation. This reduces the risk of arterial thrombosis.
• Aspirin: Irreversibly inhibits cyclooxygenase-1 (COX-1) in platelets, suppressing thromboxane A2 production, further reducing platelet aggregation.
• The combined action of these three agents addresses hyperlipidemia, platelet hyperactivity, and thrombotic risk, providing comprehensive cardiovascular protection.

Indications for Use of  Atorvastatin 10mg, Clopidogrel 75 mg, and Aspirin 75 mg Capsules

 Atorvastatin 10mg, Clopidogrel 75 mg, and Aspirin 75 mg Capsules are indicated for:

• Patients with high risk of cardiovascular events (heart attack, stroke)
• Secondary prevention in patients with established coronary artery disease or atherosclerosis
• Management of hyperlipidemia in patients with cardiovascular risk factors
• Prevention of arterial thrombosis in post-angioplasty or post-stent placement patients
• Patients requiring dual or triple therapy for combined lipid and platelet management

Dosage and Administration of Triple-Drug Combination Capsules

Normally, the recommended dosage must be according to the doctor's prescription and advice

• Recommended dose: One capsule once daily or as prescribed by a physician.
• Take the capsule preferably after meals with water to reduce gastrointestinal discomfort.
• Dosage may be adjusted based on lipid profile, platelet function tests, and clinical response.
• Regular monitoring of liver function, renal function, and bleeding parameters is recommended during therapy.

Precautions While Using Atorvastatin 10mg, Clopidogrel 75 mg, and Aspirin 75 mg Capsules

• Avoid use in patients with active bleeding, peptic ulcer disease, or severe hepatic impairment.
• Use cautiously in patients with renal dysfunction, bleeding disorders, or a history of stroke.
• Avoid concomitant use with other NSAIDs unless prescribed.
• Pregnancy and lactation: Use only if clearly indicated by a physician.
• Inform your doctor about any upcoming surgery or invasive procedure due to increased bleeding risk.

Storage Instructions

• Keep it away from direct sunlight.
• Keep it in a cool and dry place.
• Keep away from children.
• Do not keep it near moisture.
• Expired tablets are not good for health; avoid taking them.